People · Operator
Named in public records as an officer, director or promoter · active 2015–2024 · Biotech / Pharma, Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Greenlight Biosciences Inc. | — | Biotech / Pharma | Series D+ | $179.4M | $3.9B | 2015 |
| Elektrofi, Inc. | — | Biotechnology | Series D+ | $154.8M | $1.2B | 2022 |
| Mitra RxDx, Inc. | — | Other Health Care | Series C | $111.0M | $1.0B | 2018 |
| Codiak BioSciences, Inc. | — | Biotechnology | Series C | $107.5M | $3.1B | 2017 |
Charles L. Cooney at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Charles L. Cooney on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steven Gillis | 1 | 23 |
| Matthew Walker | 1 | 11 |
| Jonathan Fleming | 1 | 9 |
| Michael Liang | 1 | 9 |
| Noubar Afeyan | 1 | 9 |
| Jason Dinges | 1 | 8 |
| David Furneaux | 1 | 8 |
| Ganesh Kishore | 1 | 7 |
| Eric O'Brien | 1 | 6 |
| Andrey Zarur | 1 | 6 |
| Jason Norris | 1 | 5 |
| Doug Williams | 1 | 5 |
| Charles Cooney | 1 | 4 |
| Neil Renninger | 1 | 4 |
| Martha Schlicher | 1 | 4 |
| Greg Lucier | 1 | 2 |
| Eric Lander | 1 | 2 |
| Marta L. Ortega-Valle | 1 | 1 |
| David L. Furneaux | 1 | 1 |
| Ganesh L. Kishore | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.